Meeting
2018 Genitourinary Cancers Symposium
Association of age and sex with mortality following adjuvant therapy for renal cell cancer (RCC): Subgroup analysis of the ASSURE (E2805) trial.
Authors
Ronac Mamtani
University of Pennsylvania, Philadelphia, PA
Ronac Mamtani , Xin Victoria Wang , Robert S. DiPaola , Janice P. Dutcher , Naomi B. Haas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Clinical Trial Registration Number
NCT00326898
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 575)
DOI
10.1200/JCO.2018.36.6_suppl.575
Abstract #
575
Poster Bd #
E12
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Adjuvant therapy in high-risk renal cell cancer: A systematic review and cumulative meta-analysis.
First Author: Rabbia Siddiqi
Poster
2021 Genitourinary Cancers Symposium
Analysis of plasma KIM-1 as a biomarker for recurrence risk after resection for localized renal cell carcinoma.
First Author: Wenxin Xu
Poster
2017 ASCO Annual Meeting
A phase III study of atezolizumab (atezo) vs placebo as adjuvant therapy in renal cell carcinoma (RCC) patients (pts) at high risk of recurrence following resection (IMmotion010).
First Author: Robert Uzzo
Poster
2023 ASCO Genitourinary Cancers Symposium
Patient perceptions of benefits and risks of adjuvant therapy in renal cell carcinoma.
First Author: Dena Battle